TIDMBIOM
RNS Number : 4859Z
Biome Technologies PLC
03 September 2018
3 September 2018
Biome Technologies plc
("Biome", "the Company" or "the Group")
Interim Results
Biome Technologies plc announces its Interim Results for the six
months ended 30 June 2018.
Highlights
-- Group revenues in H1 2018 increased by 47% to GBP4.4m
compared with the comparable period last year (H1 2017:
GBP3.0m)
-- Biome generated an operating profit of GBP0.2m compared to an
operating loss of GBP0.2m in the first half of 2017
-- Group cash position at 30 June 2018 of GBP2.3m (31 December 2017: GBP2.3m)
Paul Mines, Chief Executive Officer said:
"The Group had an outstanding first half to 2018 delivering an
operating profit in the period. Opportunities within the
Bioplastics division are increasing with substantial revenue
potential in the medium term whilst the Stanelco RF division has
delivered an exceptional start to the year. It is against this
backdrop that Board remains confident in the Group's outlook for
2018."
For further information please contact: Biome
Technologies plc
Paul Mines, Chief Executive Officer
Declan Brown, Group Finance Director
www.biometechnologiesplc.com Tel: +44 (0) 2380 867
100
Allenby Capital
David Hart/Alex Brearley (Nominated Adviser)
Kelly Gardiner (Broker)
www.allenbycapital.com Tel: +44 (0) 20 3328
5656
About Biome
Biome Technologies plc is an AIM listed, growth-orientated,
commercially driven technology group. Our strategy is founded on
building market-leading positions based on patented technology and
serving international customers in valuable market sectors. We have
chosen to do this by developing products in application areas where
the value-added pricing can be justified and that are not reliant
on government legislation. These products are driven by customer
requirements and are compatible with existing manufacturing
processes. They are market rather than technology-led.
The Group comprises two divisions, Biome Bioplastics Limited and
Stanelco RF Technologies Limited. Biome Bioplastics is a leading
developer of highly-functional, bio-based and biodegradable
plastics. The company's mission is to produce bioplastics that
challenge the dominance of oil-based polymers. Stanelco RF
Technologies designs, builds and services advanced radio frequency
(RF) systems. Dielectric and induction heating products are at the
core of a product offering that ranges from portable sealing
devices to large furnaces for the fibre optics markets.
In 2018, the Board has adopted the following three high level
KPIs for the next three years to continue its ambitious
momentum:
-- Compound revenue growth of 25% per annum across the Group and
40% compound revenue growth in the Bioplastics division
-- Diversify the Group's turnover by product and market to
ensure that no one product or end customer contributes more than
15% of revenues by 2020
-- Increase investment in the Group's next generation of
products by spending significantly more per annum on average than
the GBP0.3m per annum average spend over the previous strategic
objective cycle
www.biometechnologiesplc.com
www.biomebioplastics.com
www.stanelcorftechnologies.com
Chairman's Statement
The Group has reached an important milestone in the first half
of 2018 by reporting an operating profit of GBP0.2m, substantially
ahead of the operating loss of GBP0.2m in the prior year.
Group revenues were up 47% to GBP4.4m compared to GBP3.0m in the
first half of 2017 due to an exceptional increase in revenues in
the RF Technologies division. Gross profit of GBP2.3m was ahead of
the first half of 2017 (GBP1.5m). Margins, at 53%, were ahead of
the prior year due mainly to a favourable product mix. Overheads
increased by GBP0.4m over 2017 principally reflecting increased
staffing levels to support the increase in turnover as well as
increased research and development spend associated with the next
generation of products within the Bioplastics division.
The Group recorded a profit before interest, depreciation,
amortisation and share option charges for the six months to 30 June
2018 of GBP0.5m compared to a profit of GBP0.1m in the first half
of 2017. The profit after taxation was GBP0.2m (H1 2017: loss
GBP0.2m) equating to earnings per share of 9 pence on both a basic
and diluted basis (H1 2017 loss per share 9 pence).
The Group's cash position as at 30 June 2018 was GBP2.3m (31
December 2017: GBP2.3m).
Biome Bioplastics Division
Revenues in the Bioplastics division for the first half of 2018
were GBP0.9m (H1 2017: GBP1.2m) with the turnover in the second
quarter returning to a normal pattern within the existing single
serve coffee pod packaging business. Sales of the non-woven mesh
filtration product continued to grow as expected and Biome's work
to qualify a second manufacturing site in the USA in anticipation
of additional demand is nearing completion. It is anticipated that
sales of the reformulated rigid ring material for coffee pods will
commence in Q4 2018 and testing continues in this regard.
The operating loss for the period of GBP0.3m (2017: operating
loss of GBP0.1m) reflects the impact of the lower revenues as well
as the acceleration of research and development costs associated
with next generation products and the increase in staffing resource
to support the anticipated increase in demand for bioplastics
products. The division's development compounding capabilities were
expanded to a second location in Southampton during the period.
Biome continues its strategy of developing products where there
is specific customer demand for bio-based or biodegradable
solutions. It was noted in the July 2018 trading update that two
projects in particular are advancing encouragingly through the
development phase and, if successful, could lead to substantial
revenues in 2019 and 2020. These projects are both with new
customers. One of them has now completed its technical development
phase in the USA and commercial production is expected in 2019. The
second project, being developed in continental Europe, has passed
an important milestone in recent weeks and work continues to
support an aggressive launch timetable with the customer with
commercial revenues being anticipated in 2019. Additionally, in
recent weeks an initial six-month feasibility study, supported by
an international consumer goods company, has been completed and
discussions are underway regarding a product launch in 2020.
The division has continued with its mid-term strategy to develop
a new range of lignocellulose-derived bioplastics that have
increased performance characteristics and can be made at a
comparable cost to traditional petro-chemicals. This work continues
to be supported by various government grants and during the first
half of 2018 the Company accelerated expenditure in this area. The
Company has now filed a number of patent applications to protect
the emerging technology (details of these can be found under the
Biotechnology section of the Company's Biome Bioplastics website).
Further updates on the progress of these projects will be made as
they evolve.
Positive interest remains in the UK, with the Government looking
to progress innovative material solutions to the problem of single
use plastics in the medium term. This may provide an opportunity to
accelerate our work in industrial biotechnology solutions and Biome
is engaged with a number of parties in this area.
Stanelco RF Technologies Division
Revenues in the RF Technologies division were GBP3.5m (H1 2017:
GBP1.7m) reflecting exceptional demand in the period for fibre
optic furnaces. As a result of this substantial increase in
revenues, operating profit recorded in the first half increased to
GBP1.3m (H1 2017: GBP0.6m).
Strong demand for fibre optic furnaces continues into the second
half of this year. The design and manufacturing teams have
responded very well to the rapid and significant upturn in
activity. The manufacturing footprint was expanded during the
period providing increased production capacity.
Outlook
As can be seen from the above updates, our divisions are
maximising their opportunities within quite different business
environments and the Board remains confident in the Group's outlook
for 2018.
Bioplastics is developing a position in a new market with
substantial incremental growth prospects. The recent widening of
its customer base and products under development, as its
marketplace increases in size, is giving more evidence that we will
achieve our strategic goals on the three-year horizon set out in
our last annual report.
RF Technologies operates in a highly technical, export-led and
established market for its products. It is making the most of the
demand in this exceptional period of expansion, albeit the
likelihood of continuing on the present trajectory is not
anticipated in our current strategic assessment of RF
Technologies.
The above emphasises to us the importance of both a three-year
view and the benefit of balancing the current outperformance of RF
Technologies with the substantial opportunities available to Biome
in the mid-term.
We will be updating shareholders more fully at the end of the
year regarding our KPI performance.
John Standen
Chairman
CONSOLIDATED STATEMENT
OF COMPREHENSIVE INCOME
For the period ended 30 June 2018
Total Total
for for
6 Months 6 Months Total Year
Ended Ended Ended
30 June 30 June 31 December
2018 2017 2017
Unaudited Unaudited Audited
Note GBP'000 GBP'000 GBP'000
-------------------------------------------- ----- ---------- ---------- ------------
5a -
REVENUE 5c 4,391 2,979 6,233
Cost of sales (2,068) (1,497) (3,131)
GROSS PROFIT 2,323 1,482 3,102
Administrative expenses (2,117) (1,688) (3,513)
5a -
PROFIT/(LOSS) FROM OPERATIONS 5c 206 (206) (411)
Profit/(Loss) from operations before
share options charges 311 (180) (365)
Share options charges (105) (26) (46)
Investment revenue 2 1 1
Foreign exchange gain/(loss) 8 (14) (32)
PROFIT/(LOSS) BEFORE TAXATION 216 (219) (442)
Taxation 6 - - 210
TOTAL COMPREHENSIVE INCOME FOR THE
PERIOD ATTRIBUTABLE TO THE EQUITY HOLDERS
OF THE PARENT 216 (219) (232)
========== ========== ============
Basic earnings/(loss) per share - pence 7 9 (9) (10)
Diluted earnings/(loss) per share -
pence 7 9 (9) (10)
CONSOLIDATED STATEMENT
OF FINANCIAL POSITION
As at 30 June 2018
At At At
30 June 30 June 31 December
2018 2017 2017
Unaudited Unaudited Audited
Note GBP'000 GBP'000 GBP'000
--------------------------------------- ----- ---------- ---------- ------------
NON-CURRENT ASSETS
Other intangible assets 8 891 1,035 915
Property, plant and equipment 9 161 136 122
---------- ---------- ------------
1,052 1,171 1,037
---------- ---------- ------------
CURRENT ASSETS
Inventories 10 861 630 797
Trade and other receivables 11 1,555 1,515 1,335
Cash and cash equivalents 2,307 1,885 2,293
---------- ---------- ------------
4,723 4,030 4,425
---------- ---------- ------------
TOTAL ASSETS 5,775 5,201 5,462
========== ========== ============
CURRENT LIABILITIES
Trade and other payables 12 2,063 1,871 2,125
2,063 1,871 2,125
---------- ---------- ------------
TOTAL LIABILITIES 2,063 1,871 2,125
========== ========== ============
NET ASSETS 3,712 3,330 3,337
========== ========== ============
EQUITY
Share capital 118 117 117
Share premium account 793 740 740
Capital redemption reserve 4 4 4
Share options reserve 214 480 219
Translation reserve (85) (85) (85)
Retained profits/(losses) 2,668 2,074 2,342
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS
OF THE PARENT AND TOTAL EQUITY 3,712 3,330 3,337
========== ========== ============
The interim statements were approved by the Board on 31 August
2018.
Signed on behalf of the Board of Directors
Paul R Mines (Chief Executive)
Declan L Brown (Group Finance Director)
31 August 2018
CONSOLIDATED STATEMENT
OF CHANGES IN EQUITY
As at 30 June 2018
Share Capital Share
Share premium redemption options Translation Retained TOTAL
capital account reserve reserve reserve earnings EQUITY
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Balance at 1 January
2018 117 740 4 219 (85) 2,342 3,337
========= ========= ============ ========= ============ ========== ========
Issue of share capital 1 53 - - - - 54
Share options issued
in share based payments - - - 105 - - 105
Cancellation of
time expired share
options - - - (110) - 110 -
--------- --------- ------------ --------- ------------ ---------- --------
Transactions with
owners 1 53 - (5) - 110 159
--------- --------- ------------ --------- ------------ ---------- --------
Profit for the period - - - - - 216 216
Total comprehensive
income for the period - - - - - 216 216
--------- --------- ------------ --------- ------------ ---------- --------
Balance 30 June
2018 118 793 4 214 (85) 2,668 3,712
========= ========= ============ ========= ============ ========== ========
Unaudited
Balance at 1 January
2017 117 740 4 454 (85) 2,293 3,523
========= ========= ============ ========= ============ ========== ========
Share options issued
in share based payments - - - 26 - - 26
Cancellation of
time expired share
options - - - - - - -
Transactions with
owners - - - 26 - - 26
--------- --------- ------------ --------- ------------ ---------- --------
Loss for the period - - - - - (219) (219)
Total comprehensive
income for the period - - - - - (219) (219)
--------- --------- ------------ --------- ------------ ---------- --------
Balance 30 June
2017 117 740 4 480 (85) 2,074 3,330
========= ========= ============ ========= ============ ========== ========
Share Capital Share
Share premium redemption options Translation Retained TOTAL
capital account reserve reserve reserves earnings EQUITY
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Audited
Balance at 1 January
2017 117 740 4 454 (85) 2,293 3,523
========= ========= ============ ========= ============ ========== ========
Share options issued
in share based payments - - - 46 - - 46
Cancellation of
time expired share
options - - - (281) - 281 -
Transactions with
owners - - - (235) - 281 46
--------- --------- ------------ --------- ------------ ---------- --------
Loss for the year - - - - - (232) (232)
Total comprehensive
income for the year - - - - - (232) (232)
--------- --------- ------------ --------- ------------ ---------- --------
Balance 31 December
2017 117 740 4 219 (85) 2,342 3,337
========= ========= ============ ========= ============ ========== ========
CONSOLIDATED STATEMENT
OF CASH FLOWS
For the period ended 30 June 2018
6 Months 6 Months Year
Ended Ended ended
30 June 30 June 31 December
2018 2017 2017
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
------------------------------------------- ---------- ---------- ------------
Profit/(loss) from operations 206 (206) (411)
Adjustment for:
Amortisation and impairment of intangible
assets 145 203 355
Depreciation of property, plant and
equipment 29 31 64
Share based payments 105 26 46
Foreign exchange 8 (11) (26)
---------- ---------- ------------
Operating cash flows before movement
of working capital 493 43 28
(Increase)/Decrease in inventories (63) (249) (417)
(Increase)/decrease in receivables (220) (174) 5
Increase/(decrease) in payables (62) 805 1,059
---------- ---------- ------------
Cash utilised in operations 148 425 675
Corporation tax (paid)/received - - 210
---------- ---------- ------------
Net cash inflow from operating activities 148 425 885
---------- ---------- ------------
Cash flows from investing activities
Interest received 2 1 1
Investment in intangible assets (122) (73) (106)
Purchase of property, plant and equipment (68) (3) (22)
---------- ---------- ------------
Net cash used in investing activities (188) (75) (127)
---------- ---------- ------------
Financing activities
Proceeds from issue of ordinary shares 54 - -
---------- ---------- ------------
Net cash inflow from financing activities 54 - -
---------- ---------- ------------
Net increase in cash and cash equivalents 14 350 758
Cash and cash equivalents at beginning
of period 2,293 1,535 1,535
---------- ---------- ------------
Cash and cash equivalents at end
of period 2,307 1,885 2,293
========== ========== ============
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
For the period ended 30 June 2018
1. CORPORATE INFORMATION
The financial information for the year ended 31 December 2017
set out in this interim report does not constitute statutory
accounts as defined in Section 434 of the Companies Act 2006. The
Group's statutory financial statements for the year ended 31
December 2017 have been filed with the Registrar of Companies. The
auditor's report on those financial statements was unqualified and
did not contain statements under Section 498 of the Companies Act
2006. The interim results are unaudited. Biome Technologies plc is
a public limited company incorporated and domiciled in England
& Wales. The company's shares are publicly traded on the AIM
market of the London Stock Exchange.
2. BASIS OF PREPARATION
These interim consolidated financial statements (the interim
financial statements) are for the six months ended 30 June 2018.
They have been prepared in accordance with IFRSs as adopted by the
European Union and IAS 34 Interim Financial Reporting. They do not
include all of the information required for full annual financial
statements, and should be read in conjunction with the consolidated
financial statements of the Group for the year ended 31 December
2017.
These interim financial statements have been prepared under the
historical cost convention.
These interim financial statements have been prepared in
accordance with the accounting policies adopted in the last annual
financial statements for the year to 31 December 2017 except for
the adoption of IFRS 15 as described below.
On 1 January 2018 the Group adopted IFRS 15 'Revenue from
Contracts with Customer' which supersedes IAS 18 'Revenue'. The
Group has adopted the 'Modified retrospective application' which
means there is no restatement of the comparative period but there
is an opening adjustment to retained earnings as at 1 January 2018
to account for any earnings taken in 2017 that need to be
reclassified to 2018. Following a review of all revenue streams it
has been determined that no opening adjustments with respect to the
adoption of IFRS 15 are required.
The accounting policies have been applied consistently
throughout the Group for the purposes of preparation of the interim
financial statements.
3. BASIS OF CONSOLIDATION
The Group interim financial statements consolidate the results
of the Company and all of its subsidiary undertakings drawn up to
30 June 2018. At 30 June 2018 the subsidiary undertakings were
Biome Bioplastics Limited, Stanelco RF Technologies Limited,
Aquasol Limited and InGel Technologies Limited.
4. GOING CONCERN
The directors have reviewed forecasts and budgets for the coming
12 months, which have been drawn up with appropriate regard for the
current macroeconomic environment and the particular circumstances
in which the Group operates. As a result of this process, the
directors are satisfied that the group have sufficient resources to
continue in operational existence for at least one year from the
date of approval of the interim report.
5a. SEGMENTAL INFORMATION FOR 6 MONTHSED 30 JUNE 2018
RF Central
Bioplastics Technologies Costs Total
6 Months 6 Months 6 Months 6 Months
Ended ended ended Ended
30 June 30 June 30 June 30 June
2018 2018 2018 2018
GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Revenue from external customers 932 3,459 - 4,391
(LOSS)/PROFIT FROM OPERATIONS (345) 1,279 (728) 206
Investment revenue 2
Foreign exchange gain 8
PROFIT ATTRIBUTABLE TO EQUITY
SHAREHOLDERS 216
=========
TOTAL ASSETS 1,940 1,931 1,904 5,775
================================= ============ ============== ========= =========
5b. SEGMENTAL INFORMATION FOR 6 MONTHSED 30 JUNE 2017
RF Central
Bioplastics Technologies Costs Total
6 Months 6 Months 6 Months 6 Months
ended Ended ended Ended
30 June 30 June 30 June 30 June
2017 2017 2017 2017
GBP'000 GBP'000 GBP'000 GBP'000
Unaudited
Revenue from external customers 1,241 1,738 - 2,979
(LOSS)/PROFIT FROM OPERATIONS (139) 558 (625) (206)
Investment revenue 1
Foreign exchange loss (14)
LOSS ATTRIBUTABLE TO EQUITY
SHAREHOLDERS (219)
=========
TOTAL ASSETS 1,550 1,754 1,897 5,201
================================= ============ ============== ========= =========
5c. SEGMENTAL INFORMATION FOR YEAR ENDED 31 DECEMBER 2017
RF Central
Bioplastics Technologies Costs Total
Year Year Year Year
ended ended ended ended
31 31 31
December December 31 December December
2017 2017 2017 2017
GBP'000 GBP'000 GBP'000 GBP'000
Audited
Revenue from external customers 2,279 3,954 - 6,233
(LOSS)/PROFIT FROM OPERATIONS (421) 1,338 (1,328) (411)
Investment revenue 1
Foreign exchange loss (32)
LOSS BEFORE TAXATION FROM
OPERATIONS (442)
Taxation 210
LOSS ATTRIBUTABLE TO EQUITY
SHAREHOLDERS (232)
==========
TOTAL ASSETS 1,795 1,380 2,287 5,462
================================= ============ ============== ============ ==========
6. TAXATION
The Group's policy is to recognise tax credits resulting from
tax R&D claims on a cash received basis. The claim in respect
of the year ended 31 December 2017 has not yet been settled and
there is therefore no tax credit recognised in the period under
review.
7. EARNINGS PER SHARE
The calculation of basic earnings per share is based on the
profit attributable to the equity holders of the parent for the six
months of GBP216,000 (2017: loss of GBP219,000) and a weighted
average of 2,352,465 (2017: 2,347,536) ordinary shares in
issue.
Diluted earnings per share for the six months ended 30 June 2018
were based on a weighted average of 2,484,334 shares which accounts
for all share options which are in the money, regardless of whether
they have yet vested. For 2017 the diluted earnings per share
equalled the basic earnings per share as all outstanding share
options were out of the money for the purposes of the diluted
earnings per share calculation.
8. OTHER INTANGIBLE ASSETS
Other intangible assets decreased in the period as a result of
the amortisation charge of GBP145,000 exceeding the capitalisation
of product development costs for the period of GBP122,000.
9. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment increased in the reporting period
as a result of the purchase of property, plant and equipment of
GBP68,000 being more than the depreciation charge for the period of
GBP29,000.
10. INVENTORIES
The increase in inventories during the reporting period reflects
the increase in equipment orders under construction within the
Stanelco RF division. These orders are all due for shipment to the
customers over the next few months. The increase in inventories
within the Stanelco RF division was partially offset by a decrease
in inventories within the Bioplastics division.
11. TRADE AND OTHER RECEIVABLES
Trade and other receivables have increased during in the
reporting period mainly due to the increases in accrued revenue on
the equipment orders under construction within Stanelco RF
mentioned above as well as an increase in other debtors within the
Bioplastics division.
12. TRADE AND OTHER PAYABLES
The decrease in trade and other payables during the reporting
period primarily reflects the timing of trade creditors as at the
end of the period.
13. RISKS AND UNCERTAINTIES
The principal risks and uncertainties affecting the business
activities of the Group are detailed in the Strategic Report which
can be found on pages 6-11 of the Annual Report and Financial
Statements for the year ended 31 December 2017 ("the Annual
Report"). A copy of the Annual Report and
Financial Statements is available on the Company's website at
www.biometechnologiesplc.com
The risks affecting the business remain the same as in the
Annual Report. In summary, these risks
include:
-- changes in the regulatory environments in which the Group operates
-- fluctuations in exchange rates
-- volatility in raw material prices and supply
-- breach of intellectual property rights
-- competitors developing more attractive products
-- failure to commercialise products
-- reliance on a small number of customers for certain products
-- financial risks including exchange rate risk, liquidity risk,
interest rate risk and credit risk.
Further details of how these risks impact the business and how
the directors attempt to mitigate
the risks can be found in the Annual Report.
Copies of this interim report will be shortly available on the
Company's website at www.biometechnologiesplc.com.
INDEPENDENT REVIEW REPORT FOR BIOME TECHNOLOGIES PLC
Introduction
We have reviewed the condensed set of financial statements in
the half-yearly financial report of Biome Technologies Plc (the
'company') for the six months ended 30 June 2018 which comprises
the consolidated statement of comprehensive income, consolidated
statement of financial position, consolidated statement of changes
in equity, consolidated statement of cash flows and the related
notes. We have read the other information contained in the half
yearly financial report which comprises only the Chairman's
Statement and considered whether it contains any apparent
misstatements or material inconsistencies with the information in
the condensed set of financial statements.
This report is made solely to the company, as a body, in
accordance with International Standard on Review Engagements (UK
and Ireland) 2410, 'Review of Interim Financial Information
performed by the Independent Auditor of the Entity'. Our review
work has been undertaken so that we might state to the company
those matters we are required to state to them in an independent
review report and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to
anyone other than the company as a body, for our review work, for
this report, or for the conclusion we have formed.
Directors' responsibilities
The half-yearly financial report is the responsibility of, and
has been approved by, the directors. As disclosed in note 2, the
annual financial statements of the group are prepared in accordance
with International Financial Reporting Standards as adopted by the
European Union. The condensed set of financial statements included
in this half-yearly financial report has been prepared in
accordance with International Accounting Standard 34, 'Interim
Financial Reporting', as adopted by the European Union.
Our responsibility
Our responsibility is to express a conclusion to the company on
the condensed set of financial statements in the half-yearly
financial report based on our review.
Scope of review
We conducted our review in accordance with International
Standard on Review Engagements (UK and Ireland) 2410, 'Review of
Interim Financial Information Performed by the Independent Auditor
of the Entity'. A review of interim financial information consists
of making enquiries, primarily of persons responsible for financial
and accounting matters, and applying analytical and other review
procedures. A review is substantially less in scope than an audit
conducted in accordance with International Standards on Auditing
(UK) and consequently does not enable us to obtain assurance that
we would become aware of all significant matters that might be
identified in an audit. Accordingly, we do not express an audit
opinion.
Conclusion
Based on our review, nothing has come to our attention that
causes us to believe that the condensed set of financial statements
in the half-yearly financial report for the six months ended 30
June 2018 is not prepared, in all material respects, in accordance
with International Accounting Standard 34, 'Interim Financial
Reporting', as adopted by the European Union.
GRANT THORNTON UK LLP
STATUTORY AUDITOR
CHARTERED ACCOUNTANTS
SOUTHAMPTON
31 August 2018
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IR SDMFWFFASEDA
(END) Dow Jones Newswires
September 03, 2018 02:00 ET (06:00 GMT)
Biome Technologies (AQSE:BIOM.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biome Technologies (AQSE:BIOM.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024
